HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Integrated Advisors Network LLC

Integrated Advisors Network LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 17.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,768 shares of the company's stock after purchasing an additional 869 shares during the quarter. Integrated Advisors Network LLC's holdings in HCA Healthcare were worth $1,993,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare in the 1st quarter valued at $28,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare during the 4th quarter worth $31,000. Tidemark LLC acquired a new stake in HCA Healthcare during the 4th quarter worth $36,000. Legacy Investment Solutions LLC raised its stake in HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after acquiring an additional 95 shares in the last quarter. Finally, Physician Wealth Advisors Inc. acquired a new stake in HCA Healthcare during the 4th quarter worth $64,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA traded down $0.91 during midday trading on Friday, reaching $370.76. 872,296 shares of the company's stock were exchanged, compared to its average volume of 1,449,890. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock has a market capitalization of $89.20 billion, a PE ratio of 16.88, a P/E/G ratio of 1.10 and a beta of 1.49. The business's 50-day moving average price is $358.43 and its 200 day moving average price is $333.12. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The firm had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter in the prior year, the business posted $5.36 earnings per share. HCA Healthcare's revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.78%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

HCA has been the topic of a number of recent research reports. Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Guggenheim initiated coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Finally, Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and lifted their target price for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Seven analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $392.47.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.